Monoclonal Antibodies

 Stay informed on the latest developments in monoclonal antibody production and application. Our articles cover everything from discovery to large-scale manufacturing. Single Use Support offers comprehensive solutions for the safe and efficient handling of monoclonal antibodies, ensuring maximum efficacy and safety.

Newsletter subscription

Get the latest delivered directly to your inbox!

Get the latest delivered directly to your inbox! You can unsubscribe at any time, no hard feelings. Privacy policy.

All articles about Monoclonal Antibodies

Monoclonal Antibodies

Who manufactures monoclonal antibodies? Overview of mAb companies

In this article we take a closer look at the top five companies in terms of annual revenue in the U.S., that dominate the field of antibody research, development and production. Further, we dive in the field of promising pioneers with a focus on mAb production for the use of cancer treatments. 

micheal-eder

Michael Eder

February 12, 2024

Monoclonal Antibodies

Solutions for mAb development and manufacturing

Monoclonal antibody development and manufacturing are highly specialized processes, demanding equally specialized equipment. We will discuss some essential tools and systems in this article.

BRMO

Brian Moloney

February 7, 2024

Monoclonal Antibodies

Safe handling of monoclonal antibodies: Best practices

Monoclonal antibodies bring along some special requirements in terms of safe handling. In this article, we will discover what these requirements are, and how they can be met.

Claus Exenberger - Single Use Support

Claus Exenberger

February 7, 2024

Monoclonal Antibodies

Steps in Monoclonal Antibody Production

From the selection of antigens to the utilization of bioreactors, each stage in the production journey significantly contributes to the quality, specificity, and scalability of monoclonal antibodies. With a focus on single-use technologies, we explore how innovations are shaping the future landscape of mAb production. 

Khalil Essani - Single Use Support

Khalil Essani

February 6, 2024

Monoclonal Antibodies

The 3 Most Overlooked Costs in Monoclonal Antibody Production

In the quest for efficient monoclonal antibody manufacturing, it's imperative to shed light on costs that are frequently underestimated. These costs can stem from various sources, including process development, high prices associated with biotherapeutics, and the evolving landscape of production technologies.

daniel-tischler

Daniel Tischler

February 6, 2024

Monoclonal Antibodies

Challenges in monoclonal antibody production

mAb production requires high levels of expertise and precision, as well as specialized equipment. Nonetheless, there are several challenges that manufacturers have to deal with.

Alexander Fuchs | Single Use Support

Alexander Fuchs

February 6, 2024

Monoclonal Antibodies

Antibody storage: preserving monoclonal antibodies

In many cases, antibodies need to be stored for varying time spans before further processing or administration. Hence, it is essential to mind the characteristic storage requirements of these valuable biologics.

Alexander Fuchs | Single Use Support

Alexander Fuchs

February 5, 2024

Monoclonal Antibodies

Solutions for automated aseptic filling of monoclonal antibodies

Filling monoclonal antibodies requires dedicated solutions that allow smooth and safe mAb processing. In this article, we will discuss some of the integral components in this procedure.

BRMO

Brian Moloney

February 5, 2024

Monoclonal Antibodies

What are monoclonal antibodies?

Monoclonal antibodies are frequently used in research, diagnostics, and therapeutics. But what makes them so special? In this article, we are going to find out!

micheal-eder

Michael Eder

January 18, 2024

Monoclonal Antibodies

Trends in monoclonal antibody production: Optimizing processes with single-use technology

Several trends are re-shaping monoclonal antibody manufacturing – from the minimized use of in vivo practices to the implementation of automated processes. In this article, we will highlight 5 current trends in mAb manufacturing.

Khalil Essani - Single Use Support

Khalil Essani

January 18, 2024

Monoclonal Antibodies

Scaling mAb production: From lab to large-scale

Scale-up has to be considered already in early stages of monoclonal antibody production. But what do manufacturers have to bear in mind? We'll find out in this article.

Alexander Fuchs | Single Use Support

Alexander Fuchs

January 18, 2024

Monoclonal Antibodies

Monoclonal antibody production process: a comprehensive guide

The monoclonal antibody manufacturing process is an essential cornerstone in research as well as in the production of diagnostic and therapeutic tools. Therefore, we will take a closer look at how mAbs are made – in this article.

Khalil Essani - Single Use Support

Khalil Essani

January 18, 2024

Recommended Downloads

E-Book

Case Study - Reducing Product Loss | Cost-Efficiency

A multinational CDMO (contract development and manufacturing organization) with USD 5 billion turnover develops and manufactures pharmaceuticals that are outsourced from biotechnology companies. Based on requirements the CDMO takes full responsibility of manufacturing of drug substance, cell & gene therapies and more within the contraced period of time.

E-Book

Study: Increased CHO Cell Viability with Controlled Liquid Nitrogen Freezer

The study was conducted aiming to optimize the cryogenic freezing process of the mammalian CHO-K1 cell line with an innovative controlled rate liquid nitrogen freezer (RoSS.LN2F). The study incorporated three viability assays to comprehensively assess the impact of varying freezing rates on post-thaw cell recovery | Trypan blue | LIVE/DEAD | Fluorescence.

E-Book

Navigating 5 Overlooked Challenges in Monoclonal Antibody Manufacturing

This guide for monoclonal antibody manufacturing addresses challenges in fluid and cold chain management such as: protection against cell line productivity, scalability, protein aggregation during freezing & thawing, contamination risks and efficiency in mAb production.